Ciena Total Cost of Revenue increased by 3.4% to $801.52M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 33.5%, from $600.44M to $801.52M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 9.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $421.51M | $513.59M | $564.37M | $460.26M | $547.45M | $527.20M | $537.41M | $600.58M | $644.97M | $618.95M | $643.21M | $570.75M | $522.17M | $538.36M | $664.09M | $600.44M | $673.04M | $716.31M | $774.81M | $801.52M |
| QoQ Change | — | +21.8% | +9.9% | -18.4% | +18.9% | -3.7% | +1.9% | +11.8% | +7.4% | -4.0% | +3.9% | -11.3% | -8.5% | +3.1% | +23.4% | -9.6% | +12.1% | +6.4% | +8.2% | +3.4% |
| YoY Change | — | — | — | — | +29.9% | +2.7% | -4.8% | +30.5% | +17.8% | +17.4% | +19.7% | -5.0% | -19.0% | -13.0% | +3.2% | +5.2% | +28.9% | +33.1% | +16.7% | +33.5% |